Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05985954
Title	Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	rectum adenocarcinoma colon adenocarcinoma
Therapies	Cetuximab + Encorafenib + Ulixertinib Cetuximab + Ulixertinib
Age Groups:	senior \| adult
Covered Countries	USA